Ovid Therapeutics Inc.

OVID

—

Advanced chart & tools →

Ovid Therapeutics Inc.OVID

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.74

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$7.25M

Net income

$-17.41M

Net margin

-240.1%

Gross margin

—

Dividends & financials

Ovid Therapeutics Inc. (OVID) reported revenue of $7.25M and net income of $-17.41M, or $-0.74 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.